论文部分内容阅读
目的对轻中度高血压患者行硝苯地平缓释剂的临床疗效以及药理作用进行分析。方法选取我院自2015年3月1日至2016年3月1日收治的轻中度高血压患者60例,将其按照随机数字表法均分为实验组与对照组,每组30例患者。对对照组患者行硝苯地平疗法,对实验组患者行硝苯地平缓释剂疗法,对比两组患者治疗后的血压变化情况,并对其药理作用进行分析。结果实验组患者治疗后的血压水平显著性优于对照组,差异显著,具有统计学意义(P<0.05)。结论对轻中度高血压患者行硝苯地平缓释剂的临床疗效比较显著,有效的改善了患者的血压水平,提高了患者的生活质量,且硝苯地平缓释剂更安全、有效,具有极高的临床应用价值。
Objective To analyze the clinical efficacy and pharmacological effects of nifedipine sustained-release agent in patients with mild to moderate hypertension. Methods Sixty patients with mild to moderate hypertension admitted to our hospital from March 1, 2015 to March 1, 2016 were randomly divided into experimental group and control group according to random number table method. Thirty patients in each group . Patients in the control group were treated with nifedipine, and nifedipine sustained-release therapy was used in the experimental group. The changes of blood pressure after treatment were compared between the two groups and their pharmacological effects were analyzed. Results The blood pressure level of the experimental group was significantly better than that of the control group after treatment, with significant difference (P <0.05). Conclusion The clinical efficacy of Nifedipine sustained-release agent in patients with mild to moderate hypertension is significant, which effectively improves the patients’ blood pressure level and improves the quality of life of patients. Nifedipine sustained-release agent is safer and more effective. High clinical value.